Hisamitsu Pharmaceutical Co Inc
TSE:4530
Hisamitsu Pharmaceutical Co Inc
Selling, General & Administrative
Hisamitsu Pharmaceutical Co Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
Selling, General & Administrative
-¥65.8B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Selling, General & Administrative
-¥1.1T
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Selling, General & Administrative
-¥637B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-3%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Selling, General & Administrative
-¥845.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Selling, General & Administrative
-¥114.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Astellas Pharma Inc
TSE:4503
|
Selling, General & Administrative
-¥740.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-6%
|
See Also
What is Hisamitsu Pharmaceutical Co Inc's Selling, General & Administrative?
Selling, General & Administrative
-65.8B
JPY
Based on the financial report for Feb 29, 2024, Hisamitsu Pharmaceutical Co Inc's Selling, General & Administrative amounts to -65.8B JPY.
What is Hisamitsu Pharmaceutical Co Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
1%
Over the last year, the Selling, General & Administrative growth was -28%. The average annual Selling, General & Administrative growth rates for Hisamitsu Pharmaceutical Co Inc have been -11% over the past three years , -4% over the past five years , and 1% over the past ten years .